Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Average Recommendation of “Hold” by Analysts
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven analysts that are currently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy […]
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven analysts that are currently covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy […]
